Z. Adjtoutah

Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors

E. Chamorey, V. Raimondi, M. Carles, 2021, Annals of Oncology.

Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article

G. Zalcman, D. Descamps, C. Audigier-Valette, 2021, European Journal of Cancer.

Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.

G. Leftheriotis, C. Chiaverini, F. Burel-Vandenbos, 2020, JAMA dermatology.

Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series

A. Laquérriere, S. Marret, S. Bekri, 2016, International journal of molecular sciences.